Analysis of Revenues
Paying user area
Try for free
Monsanto Co. pages available for free this week:
- Statement of Comprehensive Income
- Common-Size Income Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Profitability Ratios
- Analysis of Solvency Ratios
- Analysis of Reportable Segments
- Enterprise Value to EBITDA (EV/EBITDA)
- Capital Asset Pricing Model (CAPM)
- Selected Financial Data since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Monsanto Co. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Revenues as Reported
Monsanto Co., income statement, revenues
US$ in millions
Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).
The revenue data for various seed and agricultural product segments over the six-year period ending August 31, 2017, reveals several notable trends and fluctuations.
- Corn Seed and Traits
- Revenues showed an initial increase from 5,814 million USD in 2012 to a peak of 6,596 million USD in 2013. This was followed by a decline over the next two years, reaching a low of 5,825 million USD in 2016 before rising again to 6,270 million USD in 2017. Overall, the segment exhibited moderate volatility with a net growth over the period.
- Soybean Seed and Traits
- This segment experienced sustained growth, rising from 1,771 million USD in 2012 to 2,662 million USD in 2017. Notably, revenues increased steadily year-on-year, except for a slight dip in 2016. The upward trajectory reflects strong performance and increasing market demand.
- Cotton Seed and Traits
- Revenues declined notably from 779 million USD in 2012 to 440 million USD in 2016, representing a significant contraction. However, 2017 saw a rebound to 615 million USD. Despite the recovery, the segment ended below its initial revenue level, indicating challenges during the period.
- Vegetable Seeds
- This category displayed relative stability with minor fluctuations. Revenues started at 851 million USD in 2012, declined slightly in subsequent years, and finished at 815 million USD in 2017. The overall pattern suggests a mature market with limited growth.
- All Other Crops Seeds and Traits
- Revenues remained largely steady with some variability, beginning at 574 million USD in 2012, peaking at 760 million USD in 2016, but then decreasing to 551 million USD in 2017. The segment shows inconsistent performance and lacks a clear growth trend.
- Seeds and Genomics
- This aggregated segment reflects a general upward trend, growing from 9,789 million USD in 2012 to 10,913 million USD in 2017. Although there was a decline in 2015 and 2016, the overall direction is positive, indicating expansion in this combined category.
- Agricultural Productivity
- This segment showed significant volatility. Revenues increased sharply from 3,715 million USD in 2012 to 5,115 million USD in 2014, followed by a substantial decline to 3,514 million USD in 2016. Revenues modestly recovered to 3,727 million USD in 2017 but remained below the earlier peak. This pattern suggests exposure to fluctuating market or external factors affecting sales.
- Net Sales
- Total net sales mirrored many of the segment trends, increasing from 13,504 million USD in 2012 to a peak of 15,855 million USD in 2014. Afterwards, figures decreased to 13,502 million USD in 2016 before rising again to 14,640 million USD in 2017. This overall fluctuation highlights the impact of segment-specific performance on the consolidated revenue.
In summary, the data reflects a mixed performance across product categories, with soybean seed and traits and the overall seeds and genomics segments demonstrating growth, while cotton seed and agricultural productivity segments experienced notable volatility and declines. Total net sales exhibit a cyclical pattern with peaks in the mid-period followed by partial recoveries.